Canadian-made HIV vaccine approved for human testing

Many have tried and failed to create a vaccine that could prevent infection with HIV. Now, Canadian researchers say they’re working on one that takes a different approach.

Researchers from the University of Western Ontario in London, Ont. say they have developed an HIV vaccine that uses the whole HIV virus, unlike other attempts that have used just certain genes or proteins from the virus.

The virus has been genetically engineered to be “non-pathogenic,” meaning it can’t actually cause HIV in recipients. The idea is the vaccine would prime the body’s T-cells to destroy any cells that might become infected with HIV.

So far, the vaccine has been shown to stimulate a strong immune response in preliminary toxicology tests in lab animals, the university reports. But  it will be several years before researchers know whether it’s effective in humans.

The team announced Tuesday they have just received approval from regulators with the U.S. Food and Drug Administration to begin testing the experimental vaccine on humans. The Phase I clinical trial will begin in January using 40 volunteers who already have HIV. That phase will test the safety of the vaccine.

If all goes well, the next phases of study would test whether the vaccine is actually effective.
Read more: 

Categories: Genetics, Health, Medicine

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.